Workflow
Drug Response Predictor (DRP®)
icon
Search documents
Allarity Therapeutics(ALLR) - Prospectus
2023-06-07 10:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the Securities and Exchange Commission on June 7, 2023. FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Allarity Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 2834 87-2147982 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 24 School Street, 2nd Floor Boston, MA 0 ...
Allarity Therapeutics(ALLR) - Prospectus(update)
2023-03-28 20:16
As filed with the Securities and Exchange Commission on March 28, 2023. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 24 School Street, 2nd Floor Boston, MA 02108 Telephone: (401) 426-4664 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) James G. Cullem c/o Allarity Therapeutics, Inc. 24 School Street, 2nd Floor Boston, MA 02108 Te ...